Newsletters


Filter by volume

Agenus on Twitter

$AGEN optimal combos with allogeneic cell therapy (iNKT), checkpoint antibodies for cures in preclinical models resistant to anti-PD-1. @Agenus_Bio is well-positioned to deliver these combos from our proprietary pipeline. #AACR2020 #Cancer agenusbio.com/publications/#… twitter.com/Agenus_Bio/sta… Retweeted by Agenus Inc. ($AGEN)

At #AACR2020, $AGEN demonstrated potential for curative combinations with #celltherapy & #Checkpoint antibodies in models refractory to anti-PD-1. @Agenus_Bio proprietary pipeline is positioned to deliver these combos! #Immunotherapy #cancer

test Twitter Media - At #AACR2020, $AGEN demonstrated potential for curative combinations with #celltherapy & #Checkpoint antibodies in models refractory to anti-PD-1.  @Agenus_Bio proprietary pipeline is positioned to deliver these combos! #Immunotherapy #cancer https://t.co/mg1YfvtDqa

At #AACR2020 we @Agenus_Bio demonstrate the curative combination potential of our pipeline in models that are refractory to first generation IO therapies. $AGEN is best positioned to advance more effective combinations for cancer patients today. twitter.com/Agenus_Bio/sta… Retweeted by Agenus Inc. ($AGEN)

$AGEN Cell Therapy and Checkpoint Antibody Combinations Show Curative Preclinical Efficacy at AACR 2020 investor.agenusbio.com/2020-06-22-Age…

Agenus and Betta Pharmaceuticals Enter Into a License Agreement for Balstilimab and Zalifrelimab in Greater China investor.agenusbio.com/2020-06-22-Age…

@Agentus_CellTX CEO Walter Flamenbaum & CTO Marc Van Dijk reveal proprietary allogeneic iNKTs have potential to treat solid tumors with antibody combos (with $AGEN CPIs) affordably. iNKTs are advancing in #COVID19 & #Cancer @RaymondJames #Healthcare conference Retweeted by Agenus Inc. ($AGEN)

Experts Drs. Marc Van Dijk & Walter Flamenbaum join cell therapy expert panel @RaymondJames Conference: #CellTherapy: Promise of the Next Generation.

test Twitter Media - Experts Drs. Marc Van Dijk & Walter Flamenbaum join cell therapy expert panel @RaymondJames Conference: #CellTherapy: Promise of the Next Generation. https://t.co/0KhTIb32uQ

$AGEN will host calls with investors to address your questions every Wednesday @4PM. To register, please call 781-674-4408. Retweeted by Agenus Inc. ($AGEN)

NEWSLETTER: #ASCO20 highlights and $AGEN pipeline of Fc engineered TIGIT & CTLA-4 with our plans to unlock value for patients with #Cancer agenusbio.com/wp-content/upl…

test Twitter Media - NEWSLETTER:  #ASCO20 highlights and  $AGEN pipeline of Fc engineered TIGIT & CTLA-4 with our plans to unlock value for patients with #Cancer https://t.co/cfbidxWZj1 https://t.co/EyMF2LLDAO

TUNE IN: Shoptalk Virtual Conference with @garo_armen Chairman and CEO at @Agenus_Bio, to discuss the future of retail based on progress in COVID-19 therapeutics and vaccines on June 11 1-1:45pm ET. twitter.com/shoptalk/statu…

FDA clears IND application for natural killer T-cell therapy @Agenus_Bio @Agentus_CellTX to treat #COVID19 - phase 1 trial to come bit.ly/2Ax2Rwscome bit.ly/2 Retweeted by Agenus Inc. ($AGEN)

FBR has informed callers to use 973-413-6102 twitter.com/Agenus_Bio/sta…

EXPERT PANEL TONIGHT! Join Dr. Steven @ODayMD @JohnWayneCI, Dr. Chuck Drake @nyphospital & @columbiacancer, & Dr. Jennifer Buell from @Agenus_Bio to discuss Next Generation IO Therapies, including AGEN1181 with Mayank Mamtani from @BRileyFinancial #innovation #nextgeneration

test Twitter Media - EXPERT PANEL TONIGHT!  Join Dr. Steven @ODayMD  @JohnWayneCI, Dr. Chuck Drake @nyphospital & @columbiacancer, & Dr. Jennifer Buell from @Agenus_Bio to discuss Next Generation IO Therapies, including AGEN1181 with Mayank Mamtani from @BRileyFinancial  #innovation #nextgeneration https://t.co/omgnBDFffg

Proud to be leading the charge with @Agenus_Bio and my oncology colleagues with a next generation CTLA-4 antibody. twitter.com/jbuell01/statu… Retweeted by Agenus Inc. ($AGEN)

$AGEN sends special thanks to our AGEN1181 PIs & staff for your excellent care & continued accrual during this difficult #COVID19 pandemic: Dr. @ODayMD @JohnWayneCI; Dr El-Khouiery @USC; Dr. Gordon @HonorHealth; Dr. Bullock @BIDMChealth; Dr. Ramamurthy @UTHealthcareSA #ASCO2020

test Twitter Media - $AGEN sends special thanks to our AGEN1181 PIs & staff for your excellent care & continued accrual during this difficult #COVID19 pandemic:  Dr. @ODayMD @JohnWayneCI; Dr El-Khouiery @USC; Dr. Gordon @HonorHealth; Dr. Bullock @BIDMChealth; Dr. Ramamurthy @UTHealthcareSA #ASCO2020 https://t.co/C0AUb2LDTg

Agenus NEWSLETTER: Paulo Moriera leads path-breakers: advancing 14 new discoveries to clinic with FIM 2.5x faster than industry & readiness for 2 planned BLA filings in 2020. READ MORE: agenusbio.com/wp-content/upl…

test Twitter Media - Agenus NEWSLETTER:  Paulo Moriera leads path-breakers: advancing 14 new discoveries to clinic with FIM 2.5x faster than industry & readiness for 2 planned BLA filings in 2020. READ MORE: https://t.co/s2CWvuDPik https://t.co/FeHEFMuYjM

@beilis_jay @jbuell01 The replay will also be available on our website after the discussion: investor.agenusbio.com/presentation-w…